Levonance 30

Ethinylestradiol/Levonorgestrel, the active ingredient in Levonance 30, is a combined oral contraceptive presented as a tablet for oral use. It works to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Levonance 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this hormonal contraceptive. The company adheres to EU quality standards and ensures consistent product availability across global markets.

Levonance 30, a combined oral contraceptive, is indicated for hormonal contraception.

Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. Contraception: used as a primary method to avoid unintended pregnancy. Family planning: enables women to plan and space pregnancies according to personal goals.

Levonance 30 may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild stomach upset or queasiness. - Breast tenderness: swelling or discomfort in the breasts. - Headache: mild to moderate head pain. - Spotting: irregular uterine bleeding between periods.

Serious or Rare Side Effects: - Thromboembolic events: blood clots in veins or arteries, potentially life‑threatening. - Hepatic adenoma: benign liver tumor that may require monitoring. - Severe hypertension: markedly elevated blood pressure requiring medical attention. - Allergic reactions: rash, swelling, or anaphylaxis in rare cases.

Before prescribing Levonance 30, clinicians should consider several precautionary measures. - Contraindications: known or suspected pregnancy, active thromboembolic disease, estrogen‑dependent tumor, uncontrolled hypertension, severe liver disease. - Smoking: avoid use in women over 35 who smoke due to increased cardiovascular risk. - Medication review: assess concomitant drugs that may reduce contraceptive efficacy. - Regular monitoring: check blood pressure and lipid profile periodically during therapy. - Store at ambient temperature: keep below 25°C, protect from moisture and light in the original packaging.

Levonance 30 can interact with other medicines, affecting its effectiveness or safety.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., rifampin, carbamazepine): may significantly lower hormone levels and reduce contraceptive protection. - Certain antiretrovirals (e.g., efavirenz): can decrease oral contraceptive efficacy. - Hormonal therapies (e.g., hormone replacement): may increase risk of thromboembolic events.

Moderate Interactions (Monitor Closely): - Some antibiotics (e.g., ampicillin, tetracycline): possible modest reduction in contraceptive effect. - Selective serotonin reuptake inhibitors (SSRIs): may heighten risk of mood changes or bleeding.